Artificial intelligence technology has become a major game-changer in the field of cancer radiotherapy. With its ability to significantly reduce patient waiting times, this cutting-edge technology will be provided to all National Health Service (NHS) trusts in England at cost price. By precisely calculating the direction of radiation beams for treatment, AI helps doctors accurately locate cancer cells while minimizing damage to healthy cells.
In the past decade, researchers at Addenbrooke's Hospital have tirelessly worked on developing this groundbreaking AI program. They collaborated with Microsoft to train an AI program called InnerEye using data from previous patients. Traditionally, doctors would spend 25 minutes to 2 hours drawing or outlining bones and organs on around 100 scan slices for each patient. However, InnerEye works 2.5 times faster than the traditional method.
The importance of this technology becomes evident when considering sensitive treatment areas such as prostate, head, and neck cancers. In these cases, the goal for healthcare professionals is to avoid damaging nearby organs like the bladder or rectum, which can lead to lifelong incontinence issues. Dr. Raj Jena, a leading expert at Addenbrooke's Hospital, explains, "This can become really bad to the point where patients' lives are governed by this problem. I know patients who carry city maps with them on their journeys to know where all the toilets are."
The collaboration between Addenbrooke's Hospital and Microsoft has achieved breakthrough technological advancements, greatly reducing the time required for drawing. While doctors typically spend several hours carefully outlining scan images, the AI program is able to complete this task faster, allowing healthcare professionals to focus on other critical aspects of patient care.
Dr. Katharine Halliday, President of the Royal College of Radiologists, expresses excitement about the potential of AI in replacing certain processes and procedures, including diagnosis and cancer treatment. AI has the ability to expedite the diagnostic process, enabling doctors to detect diseases earlier and provide patients with the best chances of recovery.
It is important to note that AI programs are not meant to replace clinical radiologists but rather enhance their capabilities. Although doctors still need to review and validate the contours drawn by AI programs, the impressive accuracy rate of around 90% often leads clinical doctors to approve the AI's work without any corrections. This high level of accuracy even makes some consultants prefer the work of AI over their human colleagues.
Dr. Katharine Halliday emphasizes, "AI shows great potential to help alleviate the strain on a stretched workforce, but it cannot replace trained and skilled professionals." AI, with its data-driven insights and accuracy, complements the expertise of clinical radiologists and becomes a powerful force in patient care.
The development of this AI program marks a significant milestone in NHS's investment in AI projects. As the first AI program released as a medical imaging device developed by the NHS, InnerEye represents a major advancement in utilizing AI to improve patient treatment outcomes. The NHS AI Lab provided £500,000 in funding to Addenbrooke's Hospital for necessary safety checks and evaluations.
Now, the program will be provided to a manufacturer who has agreed to offer the cloud technology usage rights to other NHS trusts at cost price. This initiative demonstrates NHS's commitment to harnessing the potential of AI and ensuring that all patients within the UK have access to this cutting-edge technology.
Integrating AI into cancer radiotherapy is undoubtedly changing the landscape of patient care. By reducing drawing time and improving the accuracy of treatment plans, AI empowers doctors to provide more precise and efficient treatments. Patients can benefit from reduced side effects and improved quality of life during and after treatment.
As AI continues to evolve and healthcare undergoes innovation, striking a balance between technological advancements and the irreplaceable expertise of healthcare professionals is crucial. The combination of AI and clinical radiologists has the potential to bring significant improvements in patient care, enabling earlier disease detection and providing patients with the best chances of recovery.
With NHS leading the way in AI implementation, we can expect further innovation and breakthroughs in the field of cancer treatment and diagnosis. As AI becomes a part of healthcare, it has the potential to enhance patient management and fundamentally transform the future of medicine.
Source: https://readwrite.com/ai-technology-drastically-cuts-treatment-time-for-cancer-radiotherapy/
Alphabet Q1 paid subscribers reached 350M, fueled by YouTube & Google One. YouTube ad revenue slightly missed at $9.88B amid Premium growth. Total Q1 revenue hit $109.9B, beating forecasts.
Anthropic releases Claude connectors for Adobe, Blender, and Ableton, enabling AI workflow automation and app control. It also sponsors the Blender Development Foundation.
Apple introduces an App Store model splitting 12-month plans into monthly installments. On iOS 26.4+, it lowers upfront costs without reducing total price, adding billing tracking.
Google launches Aadhaar digital IDs in Wallet for India, enabling secure QR/NFC verification. A phased partner rollout targets key sectors, while passport-based credentials expand globally.
YouTube tests "Ask YouTube," an AI tool blending text and video for complex queries. Initially for US Premium users, it supports interactive follow-ups, expanding Google's AI search.
Google grants US DoD classified AI access, joining OpenAI and xAI in defense deals amid Anthropic's dispute. Contractual safeguards against surveillance and lethal weapons remain unenforceable.
Mistral AI launches Workflows, a Temporal-powered orchestration platform for secure, Python-driven enterprise AI automation featuring human-in-the-loop approvals.